Odyssey Therapeutics, Inc. Common Stock (ODTX) — Defensive Interval Ratio
Odyssey Therapeutics, Inc. Common Stock (ODTX) has a Defensive Interval Ratio of 2948 days as of June 2026. Defensive assets of $228.54 Million (cash $-, short-term investments $228.54 Million, receivables $-) cover 2948 days of daily cash needs of $77.52K/day. Explore Odyssey Therapeutics, Inc. Common Stock (ODTX) long-term investment share to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Odyssey Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Odyssey Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 2948 days, meaning defensive assets of $228.54 Million can fund 2948 days of operations without new revenue. Read ODTX current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Odyssey Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Odyssey Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Odyssey Therapeutics, Inc. Common Stock (ODTX) total assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1926 days | $139.67 Million | $72.53K/day | $- | $139.67 Million | ▲ +1024 days |
| 2024 | 902 days | $70.22 Million | $77.85K/day | $- | $70.22 Million | ▼ -1320 days |
| 2023 | 2222 days | $134.45 Million | $60.51K/day | $- | $134.45 Million | ▲ +2222 days |
| 2022 | 0 days | $0.00 | $62.46K/day | $- | $0.00 | — |